News

Patients who have either chronic idiopathic urticaria (CIU) or chronic spontaneous urticaria (CSU) who take oral corticosteroids (OCS) face a greater risk of side effects as well as higher total healthcare costs, according to a recent study.

Although antiretroviral therapy is effective in suppressing HIV-1 replication, it does not eradicate the virus and it requires lifelong adherence to the therapy. Authors of a new study say that bNAbs may be the key.

Prisoners who are able to get hepatitis C antivirals while they are still incarcerated can be lost to treatment when they are freed. A community linkage program in the Bronx, NY is having success keeping the patients on their drug regimens.

Monthly Avastin injections and quarterly Ozurdex injections produced equivalent improvements in best-corrected visual acuity after 7 months. However, Ozurdex reduced central subfield thickness nine times more than Avastin did, though it was associated with elevated intraocular pressure.

The MD Magazine editors rounded up the 10 best stories from November – did you read them all?

Donald Trump's pick of Tom Price, MD, to head Health and Human Services has enraged some groups, troubled others, and made the American Medical Association happy.

When patients with chronic kidney disease also have untreated hepatitis C, the prognosis is grim. The combination can lead to end-stage renal disease, a study found.

Santen Pharmaceutical Co., Ltd. today announced topline results from a phase 3 trial of Opsiria, a sirolimus injection intended to treat non-infectious posterior uveitis.

Some of the different hepatitis C genotypes are more prominent in certain areas than others, and researchers specified where they're found around the world in people who inject drugs.

An online self-help intervention program can improve attention deficit hyperactivity disorder (ADHD) behaviors in children and increase satisfaction in a parental role.

Antidepressant remission rates could be influenced by a precise sleeping schedule, according to findings presented in The Journal of Clinical Psychiatry.

Patients with intermediate uveitis (IU) have a high likelihood of achieving good long-term visual outcomes, but should expect a long disease course and frequent complications

Researchers concerned about inconsistencies in rating disease activity in uveitis have come up with a new scoring system called UVEDAI.

Adalimumab has the potential to serve an important role in management of chronic and refractory noninfectious uveitis and associated macular edema with low rates of serious adverse events in the long term, according to a recent report. That includes pediatric patients.

Though air pollution has previously been associated with elevated rates of atopic dermatitis (AD), the reason for that correlation remained mostly a mystery until last week.

Cytomegalovirus or CMV’s an etiological factor in patients with hypertensive anterior uveitis in Korea, according to a recent study.

Severe asthma persists in nonsmoking and smoking patients on currently recommended therapy despite suppressed tissue inflammation within the proximal airway wall, according to a recent report.

Noninfectious uveitis (NIU) is more prevalent among female than male adults and the number of cases increase in tandem with age, according to a recent study.

Comprehensive care of post-9/11 asthma in adolescents should include management of mental health-related comorbidities, according to a recent report.

As the field of medical ethics continues to expand, its use can be seen in everything from general medical conditions to end of life considerations.

Following a stroke, the sooner a patient undergoes clot-busting endovascular thrombectomy, the better their outcomes are, in terms of severity of disability.

Adalimumab (ADA) works well as a treatment for patients with both active and inactive uveitis whether or not they are taking an immunosuppressant (IMM); however, the median time to treatment failure (mTTF) is longer for patients with inactive uveitis taking an IMM.

As with most surgical advances, new potential procedures in ophthalmology pose their fair share of risks. However, if those risks can be overcome the rewards to patients can make a significant difference in their quality of life.

Panuveitis is associated with recurrent or persistent inflammation (R/PI) for patients with both active and inactive uveitis, a study found.

As a retinal implant, the ARGUS II technology has shown early benefits for patients with retinitis pigmentosa. A new study from the United Kingdom is examining its benefits in patients with the dry form of age related macular degeneration.

As with all new technologies for surgical procedures, there will be questions to be answered about the safety for hypersonic vitrectomy. While human trials have not started yet, there are good indications in cadaveric and animal studies.

Researchers suggest that family-based cognitive behavioral therapy may be a key factor in treating children with autism spectrum disorder who have problems sleeping.

After a newspaper report found that less than 10 of Tennessee's thousands of HCV-positive prisoners were receiving treatment, two inmates sued the state. Now, prison officials are seeking a bit more help in battling the disease.

Just in time for Thanksgiving, a recent study notes that foodborne transmission of Clostridium difficile is a distinct possibility.

If you’re planning on chowing down on turkey this Thanksgiving (as you should), make sure to time your meal just right, because you may be well into a nap before the Cowboys-Redskins game kicks off.